Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan

Genotypes of hepatitis B virus (HBV) were determined in 145 patients with acute hepatitis B from various districts in Japan to establish their geographic distribution and evaluating the influence on the clinical illness and outcome. Genotypes were A in 27 (19 %) patients, B in 8 (5 %), C in 109 (75 %) and mixed with B and C in the remaining one (1 %). Genotype A was more frequent in metropolitan than the other areas (21/69 (30 %) vs. 6/76 (8 %), P < 0.001). On phylogenetic analysis, seven of the nine (78 %) HBV/A isolates selected at random clustered with those from Europe and the United States, while the remaining two with those of subgroup A' prevalent in Asia and Africa. Maximum ALT levels were lower (2069 1075 vs. 2889 1867 IU/L, P = 0.03) and baseline HBV DNA titers were higher (5.90 +/- 1.45 vs. 5.13 +/- 1.36 log genome equivalents (LGE)/ml, P = 0.002) in patients infected with genotype A than C. Hepatitis B surface antigen persisted longer in patients infected with genotype A than C (1.95 +/- 1.09 vs. 1.28 +/- 1.42 months, P = 0.02). HBV infection became chronic in one (4 %) patient with genotype A and one (11 %) with genotype C infection. Fulminant hepatic failure developed in none of the patients with genotype A, one (13 %) with genotype B and five (5 %) with genotype C. The point mutation in the precore region (A1896) or the double mutations in the basic core promoter (BCP) region (T1762/A1764) were detected in none of the patients with genotype A, two (25 %) with genotype B and 27 (26 %) with genotype C. In conclusion, genotype A is frequent in patients with acute hepatitis B in metropolitan areas of Japan, probably reflecting particular transmission routes, and associated with longer and milder clinical course than genotype C. (c) 2005 Wiley-Liss, Inc.